カテゴリー： 世界, 医療/バイオ, LP Information

世界の先進的非経口薬物送達市場予測 2023年-2029年

【英語タイトル】Global Advanced Parenteral Drug Delivery Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4002）・商品コード：LP23MY4002
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の先進的非経口薬物送達市場」は、過去の販売実績から2022年の世界の先進的非経口薬物送達の総販売量を検討し、2023年から2029年の予測される先進的非経口薬物送達の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の先進的非経口薬物送達の市場規模を掲載し、XXX百万米ドル規模の世界の先進的非経口薬物送達市場の詳細な分析を提供します。本インサイトレポートは、世界の先進的非経口薬物送達業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の先進的非経口薬物送達市場における各社の独自のポジションをより深く理解するために、先進的非経口薬物送達製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の先進的非経口薬物送達市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。先進的非経口薬物送達の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。先進的非経口薬物送達の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。先進的非経口薬物送達のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

先進的非経口薬物送達の世界主要メーカーとしては、Abbott Laboratories、 Amgen、 Pfizer、 Hoffmann-La Roche、 AstraZeneca、 Baxter、 Dickinson、 Boston Scientific、 Bristol-Myers Squibb、 GlaxoSmithKline、 Novartis、 Becton、 AptarGroupなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の先進的非経口薬物送達市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では先進的非経口薬物送達市場をセグメンテーションし、種類別 (プレフィルシリンジ、インジェクターカートリッジ、皮下シリンジ、IVカテーテル、その他)、用途別 (公立病院、私立病院・診療所、医療機関、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：プレフィルシリンジ、インジェクターカートリッジ、皮下シリンジ、IVカテーテル、その他

・用途別区分：公立病院、私立病院・診療所、医療機関、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の先進的非経口薬物送達市場の10年間の市場状況・展望は？
・世界および地域別に見た先進的非経口薬物送達市場成長の要因は何か？
・先進的非経口薬物送達の市場機会はエンドマーケットの規模によってどのように変化するのか？
・先進的非経口薬物送達のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：先進的非経口薬物送達の年間販売量2018-2029、地域別現状・将来分析
・先進的非経口薬物送達の種類別セグメント：プレフィルシリンジ、インジェクターカートリッジ、皮下シリンジ、IVカテーテル、その他
・先進的非経口薬物送達の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・先進的非経口薬物送達の用途別セグメント：公立病院、私立病院・診療所、医療機関、その他
・先進的非経口薬物送達の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の先進的非経口薬物送達市場
・企業別のグローバル先進的非経口薬物送達市場データ：2018-2023年の年間販売量、市場シェア
・企業別の先進的非経口薬物送達の年間売上：2018-2023年の売上、市場シェア
・企業別の先進的非経口薬物送達販売価格
・主要企業の先進的非経口薬物送達生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

先進的非経口薬物送達の地域別レビュー
・地域別の先進的非経口薬物送達市場規模2018-2023：年間販売量、売上
・主要国別の先進的非経口薬物送達市場規模2018-2023：年間販売量、売上
・南北アメリカの先進的非経口薬物送達販売の成長
・アジア太平洋の先進的非経口薬物送達販売の成長
・ヨーロッパの先進的非経口薬物送達販売の成長
・中東・アフリカの先進的非経口薬物送達販売の成長

南北アメリカ市場
・南北アメリカの国別の先進的非経口薬物送達販売量、売上（2018-2023）
・南北アメリカの先進的非経口薬物送達の種類別販売量
・南北アメリカの先進的非経口薬物送達の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の先進的非経口薬物送達販売量、売上（2018-2023）
・アジア太平洋の先進的非経口薬物送達の種類別販売量
・アジア太平洋の先進的非経口薬物送達の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の先進的非経口薬物送達販売量、売上（2018-2023）
・ヨーロッパの先進的非経口薬物送達の種類別販売量
・ヨーロッパの先進的非経口薬物送達の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の先進的非経口薬物送達販売量、売上（2018-2023）
・中東・アフリカの先進的非経口薬物送達の種類別販売量
・中東・アフリカの先進的非経口薬物送達の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・先進的非経口薬物送達の製造コスト構造分析
・先進的非経口薬物送達の製造プロセス分析
・先進的非経口薬物送達の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・先進的非経口薬物送達の主要なグローバル販売業者
・先進的非経口薬物送達の主要なグローバル顧客

地域別の先進的非経口薬物送達市場予測レビュー
・地域別の先進的非経口薬物送達市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・先進的非経口薬物送達の種類別市場規模予測
・先進的非経口薬物送達の用途別市場規模予測

主要企業分析
Abbott Laboratories、 Amgen、 Pfizer、 Hoffmann-La Roche、 AstraZeneca、 Baxter、 Dickinson、 Boston Scientific、 Bristol-Myers Squibb、 GlaxoSmithKline、 Novartis、 Becton、 AptarGroup
・企業情報
・先進的非経口薬物送達製品
・先進的非経口薬物送達販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
LPI (LP Information)’ newest research report, the “Advanced Parenteral Drug Delivery Industry Forecast” looks at past sales and reviews total world Advanced Parenteral Drug Delivery sales in 2022, providing a comprehensive analysis by region and market sector of projected Advanced Parenteral Drug Delivery sales for 2023 through 2029. With Advanced Parenteral Drug Delivery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advanced Parenteral Drug Delivery industry.
This Insight Report provides a comprehensive analysis of the global Advanced Parenteral Drug Delivery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Advanced Parenteral Drug Delivery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Advanced Parenteral Drug Delivery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advanced Parenteral Drug Delivery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advanced Parenteral Drug Delivery.
The global Advanced Parenteral Drug Delivery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
This report presents a comprehensive overview, market shares, and growth opportunities of Advanced Parenteral Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
Segmentation by application
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Key Questions Addressed in this Report
What is the 10-year outlook for the global Advanced Parenteral Drug Delivery market?
What factors are driving Advanced Parenteral Drug Delivery market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Advanced Parenteral Drug Delivery market opportunities vary by end market size?
How does Advanced Parenteral Drug Delivery break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Advanced Parenteral Drug Delivery Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Advanced Parenteral Drug Delivery by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Advanced Parenteral Drug Delivery by Country/Region, 2018, 2022 & 2029
2.2 Advanced Parenteral Drug Delivery Segment by Type
2.2.1 Prefillable Syringes
2.2.2 Injectors Cartridges
2.2.3 Hypodermic Syringes
2.2.4 IV Catheters
2.2.5 Other Parenteral Delivery Devices
2.3 Advanced Parenteral Drug Delivery Sales by Type
2.3.1 Global Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
2.3.2 Global Advanced Parenteral Drug Delivery Revenue and Market Share by Type (2018-2023)
2.3.3 Global Advanced Parenteral Drug Delivery Sale Price by Type (2018-2023)
2.4 Advanced Parenteral Drug Delivery Segment by Application
2.4.1 Government Hospitals
2.4.2 Private Hospitals and Clinics
2.4.3 Healthcare Organizations
2.4.4 Others
2.5 Advanced Parenteral Drug Delivery Sales by Application
2.5.1 Global Advanced Parenteral Drug Delivery Sale Market Share by Application (2018-2023)
2.5.2 Global Advanced Parenteral Drug Delivery Revenue and Market Share by Application (2018-2023)
2.5.3 Global Advanced Parenteral Drug Delivery Sale Price by Application (2018-2023)
3 Global Advanced Parenteral Drug Delivery by Company
3.1 Global Advanced Parenteral Drug Delivery Breakdown Data by Company
3.1.1 Global Advanced Parenteral Drug Delivery Annual Sales by Company (2018-2023)
3.1.2 Global Advanced Parenteral Drug Delivery Sales Market Share by Company (2018-2023)
3.2 Global Advanced Parenteral Drug Delivery Annual Revenue by Company (2018-2023)
3.2.1 Global Advanced Parenteral Drug Delivery Revenue by Company (2018-2023)
3.2.2 Global Advanced Parenteral Drug Delivery Revenue Market Share by Company (2018-2023)
3.3 Global Advanced Parenteral Drug Delivery Sale Price by Company
3.4 Key Manufacturers Advanced Parenteral Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Advanced Parenteral Drug Delivery Product Location Distribution
3.4.2 Players Advanced Parenteral Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Advanced Parenteral Drug Delivery by Geographic Region
4.1 World Historic Advanced Parenteral Drug Delivery Market Size by Geographic Region (2018-2023)
4.1.1 Global Advanced Parenteral Drug Delivery Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Advanced Parenteral Drug Delivery Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Advanced Parenteral Drug Delivery Market Size by Country/Region (2018-2023)
4.2.1 Global Advanced Parenteral Drug Delivery Annual Sales by Country/Region (2018-2023)
4.2.2 Global Advanced Parenteral Drug Delivery Annual Revenue by Country/Region (2018-2023)
4.3 Americas Advanced Parenteral Drug Delivery Sales Growth
4.4 APAC Advanced Parenteral Drug Delivery Sales Growth
4.5 Europe Advanced Parenteral Drug Delivery Sales Growth
4.6 Middle East & Africa Advanced Parenteral Drug Delivery Sales Growth
5 Americas
5.1 Americas Advanced Parenteral Drug Delivery Sales by Country
5.1.1 Americas Advanced Parenteral Drug Delivery Sales by Country (2018-2023)
5.1.2 Americas Advanced Parenteral Drug Delivery Revenue by Country (2018-2023)
5.2 Americas Advanced Parenteral Drug Delivery Sales by Type
5.3 Americas Advanced Parenteral Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Advanced Parenteral Drug Delivery Sales by Region
6.1.1 APAC Advanced Parenteral Drug Delivery Sales by Region (2018-2023)
6.1.2 APAC Advanced Parenteral Drug Delivery Revenue by Region (2018-2023)
6.2 APAC Advanced Parenteral Drug Delivery Sales by Type
6.3 APAC Advanced Parenteral Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Advanced Parenteral Drug Delivery by Country
7.1.1 Europe Advanced Parenteral Drug Delivery Sales by Country (2018-2023)
7.1.2 Europe Advanced Parenteral Drug Delivery Revenue by Country (2018-2023)
7.2 Europe Advanced Parenteral Drug Delivery Sales by Type
7.3 Europe Advanced Parenteral Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Advanced Parenteral Drug Delivery by Country
8.1.1 Middle East & Africa Advanced Parenteral Drug Delivery Sales by Country (2018-2023)
8.1.2 Middle East & Africa Advanced Parenteral Drug Delivery Revenue by Country (2018-2023)
8.2 Middle East & Africa Advanced Parenteral Drug Delivery Sales by Type
8.3 Middle East & Africa Advanced Parenteral Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Advanced Parenteral Drug Delivery
10.3 Manufacturing Process Analysis of Advanced Parenteral Drug Delivery
10.4 Industry Chain Structure of Advanced Parenteral Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Advanced Parenteral Drug Delivery Distributors
11.3 Advanced Parenteral Drug Delivery Customer
12 World Forecast Review for Advanced Parenteral Drug Delivery by Geographic Region
12.1 Global Advanced Parenteral Drug Delivery Market Size Forecast by Region
12.1.1 Global Advanced Parenteral Drug Delivery Forecast by Region (2024-2029)
12.1.2 Global Advanced Parenteral Drug Delivery Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Advanced Parenteral Drug Delivery Forecast by Type
12.7 Global Advanced Parenteral Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.2.3 Amgen Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.3.3 Pfizer Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Hoffmann-La Roche
13.4.1 Hoffmann-La Roche Company Information
13.4.2 Hoffmann-La Roche Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.4.3 Hoffmann-La Roche Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hoffmann-La Roche Main Business Overview
13.4.5 Hoffmann-La Roche Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.5.3 AstraZeneca Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Baxter
13.6.1 Baxter Company Information
13.6.2 Baxter Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.6.3 Baxter Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Baxter Main Business Overview
13.6.5 Baxter Latest Developments
13.7 Dickinson
13.7.1 Dickinson Company Information
13.7.2 Dickinson Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.7.3 Dickinson Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Dickinson Main Business Overview
13.7.5 Dickinson Latest Developments
13.8 Boston Scientific
13.8.1 Boston Scientific Company Information
13.8.2 Boston Scientific Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.8.3 Boston Scientific Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Boston Scientific Main Business Overview
13.8.5 Boston Scientific Latest Developments
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Information
13.9.2 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.9.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bristol-Myers Squibb Main Business Overview
13.9.5 Bristol-Myers Squibb Latest Developments
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Information
13.10.2 GlaxoSmithKline Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.10.3 GlaxoSmithKline Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GlaxoSmithKline Main Business Overview
13.10.5 GlaxoSmithKline Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.11.3 Novartis Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Becton
13.12.1 Becton Company Information
13.12.2 Becton Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.12.3 Becton Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Becton Main Business Overview
13.12.5 Becton Latest Developments
13.13 AptarGroup
13.13.1 AptarGroup Company Information
13.13.2 AptarGroup Advanced Parenteral Drug Delivery Product Portfolios and Specifications
13.13.3 AptarGroup Advanced Parenteral Drug Delivery Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AptarGroup Main Business Overview
13.13.5 AptarGroup Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Advanced Parenteral Drug Delivery Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Advanced Parenteral Drug Delivery Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prefillable Syringes
Table 4. Major Players of Injectors Cartridges
Table 5. Major Players of Hypodermic Syringes
Table 6. Major Players of IV Catheters
Table 7. Major Players of Other Parenteral Delivery Devices
Table 8. Global Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 9. Global Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Table 10. Global Advanced Parenteral Drug Delivery Revenue by Type (2018-2023) & ($ million)
Table 11. Global Advanced Parenteral Drug Delivery Revenue Market Share by Type (2018-2023)
Table 12. Global Advanced Parenteral Drug Delivery Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Advanced Parenteral Drug Delivery Sales by Application (2018-2023) & (K Units)
Table 14. Global Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Table 15. Global Advanced Parenteral Drug Delivery Revenue by Application (2018-2023)
Table 16. Global Advanced Parenteral Drug Delivery Revenue Market Share by Application (2018-2023)
Table 17. Global Advanced Parenteral Drug Delivery Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Advanced Parenteral Drug Delivery Sales by Company (2018-2023) & (K Units)
Table 19. Global Advanced Parenteral Drug Delivery Sales Market Share by Company (2018-2023)
Table 20. Global Advanced Parenteral Drug Delivery Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Advanced Parenteral Drug Delivery Revenue Market Share by Company (2018-2023)
Table 22. Global Advanced Parenteral Drug Delivery Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Advanced Parenteral Drug Delivery Producing Area Distribution and Sales Area
Table 24. Players Advanced Parenteral Drug Delivery Products Offered
Table 25. Advanced Parenteral Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Advanced Parenteral Drug Delivery Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Advanced Parenteral Drug Delivery Sales Market Share Geographic Region (2018-2023)
Table 30. Global Advanced Parenteral Drug Delivery Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Advanced Parenteral Drug Delivery Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Advanced Parenteral Drug Delivery Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Advanced Parenteral Drug Delivery Sales Market Share by Country/Region (2018-2023)
Table 34. Global Advanced Parenteral Drug Delivery Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Advanced Parenteral Drug Delivery Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 37. Americas Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 38. Americas Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 40. Americas Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 41. Americas Advanced Parenteral Drug Delivery Sales by Application (2018-2023) & (K Units)
Table 42. APAC Advanced Parenteral Drug Delivery Sales by Region (2018-2023) & (K Units)
Table 43. APAC Advanced Parenteral Drug Delivery Sales Market Share by Region (2018-2023)
Table 44. APAC Advanced Parenteral Drug Delivery Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Advanced Parenteral Drug Delivery Revenue Market Share by Region (2018-2023)
Table 46. APAC Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 47. APAC Advanced Parenteral Drug Delivery Sales by Application (2018-2023) & (K Units)
Table 48. Europe Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 49. Europe Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 50. Europe Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 52. Europe Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 53. Europe Advanced Parenteral Drug Delivery Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Advanced Parenteral Drug Delivery Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Advanced Parenteral Drug Delivery Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Advanced Parenteral Drug Delivery Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Advanced Parenteral Drug Delivery Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Advanced Parenteral Drug Delivery Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Advanced Parenteral Drug Delivery Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Advanced Parenteral Drug Delivery
Table 61. Key Market Challenges & Risks of Advanced Parenteral Drug Delivery
Table 62. Key Industry Trends of Advanced Parenteral Drug Delivery
Table 63. Advanced Parenteral Drug Delivery Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Advanced Parenteral Drug Delivery Distributors List
Table 66. Advanced Parenteral Drug Delivery Customer List
Table 67. Global Advanced Parenteral Drug Delivery Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Advanced Parenteral Drug Delivery Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Advanced Parenteral Drug Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Advanced Parenteral Drug Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Advanced Parenteral Drug Delivery Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Advanced Parenteral Drug Delivery Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Advanced Parenteral Drug Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Advanced Parenteral Drug Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Advanced Parenteral Drug Delivery Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Advanced Parenteral Drug Delivery Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Advanced Parenteral Drug Delivery Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Advanced Parenteral Drug Delivery Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Advanced Parenteral Drug Delivery Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Advanced Parenteral Drug Delivery Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Abbott Laboratories Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 82. Abbott Laboratories Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 83. Abbott Laboratories Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. Abbott Laboratories Main Business
Table 85. Abbott Laboratories Latest Developments
Table 86. Amgen Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 87. Amgen Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 88. Amgen Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. Pfizer Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 93. Pfizer Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Hoffmann-La Roche Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 97. Hoffmann-La Roche Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 98. Hoffmann-La Roche Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Hoffmann-La Roche Main Business
Table 100. Hoffmann-La Roche Latest Developments
Table 101. AstraZeneca Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 103. AstraZeneca Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. Baxter Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 107. Baxter Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 108. Baxter Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. Baxter Main Business
Table 110. Baxter Latest Developments
Table 111. Dickinson Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 112. Dickinson Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 113. Dickinson Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Dickinson Main Business
Table 115. Dickinson Latest Developments
Table 116. Boston Scientific Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 117. Boston Scientific Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 118. Boston Scientific Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Boston Scientific Main Business
Table 120. Boston Scientific Latest Developments
Table 121. Bristol-Myers Squibb Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 122. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 123. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Bristol-Myers Squibb Main Business
Table 125. Bristol-Myers Squibb Latest Developments
Table 126. GlaxoSmithKline Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 127. GlaxoSmithKline Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 128. GlaxoSmithKline Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. GlaxoSmithKline Main Business
Table 130. GlaxoSmithKline Latest Developments
Table 131. Novartis Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 133. Novartis Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. Novartis Main Business
Table 135. Novartis Latest Developments
Table 136. Becton Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 137. Becton Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 138. Becton Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 139. Becton Main Business
Table 140. Becton Latest Developments
Table 141. AptarGroup Basic Information, Advanced Parenteral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 142. AptarGroup Advanced Parenteral Drug Delivery Product Portfolios and Specifications
Table 143. AptarGroup Advanced Parenteral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 144. AptarGroup Main Business
Table 145. AptarGroup Latest Developments
List of Figures
Figure 1. Picture of Advanced Parenteral Drug Delivery
Figure 2. Advanced Parenteral Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Advanced Parenteral Drug Delivery Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Advanced Parenteral Drug Delivery Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Advanced Parenteral Drug Delivery Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prefillable Syringes
Figure 10. Product Picture of Injectors Cartridges
Figure 11. Product Picture of Hypodermic Syringes
Figure 12. Product Picture of IV Catheters
Figure 13. Product Picture of Other Parenteral Delivery Devices
Figure 14. Global Advanced Parenteral Drug Delivery Sales Market Share by Type in 2022
Figure 15. Global Advanced Parenteral Drug Delivery Revenue Market Share by Type (2018-2023)
Figure 16. Advanced Parenteral Drug Delivery Consumed in Government Hospitals
Figure 17. Global Advanced Parenteral Drug Delivery Market: Government Hospitals (2018-2023) & (K Units)
Figure 18. Advanced Parenteral Drug Delivery Consumed in Private Hospitals and Clinics
Figure 19. Global Advanced Parenteral Drug Delivery Market: Private Hospitals and Clinics (2018-2023) & (K Units)
Figure 20. Advanced Parenteral Drug Delivery Consumed in Healthcare Organizations
Figure 21. Global Advanced Parenteral Drug Delivery Market: Healthcare Organizations (2018-2023) & (K Units)
Figure 22. Advanced Parenteral Drug Delivery Consumed in Others
Figure 23. Global Advanced Parenteral Drug Delivery Market: Others (2018-2023) & (K Units)
Figure 24. Global Advanced Parenteral Drug Delivery Sales Market Share by Application (2022)
Figure 25. Global Advanced Parenteral Drug Delivery Revenue Market Share by Application in 2022
Figure 26. Advanced Parenteral Drug Delivery Sales Market by Company in 2022 (K Units)
Figure 27. Global Advanced Parenteral Drug Delivery Sales Market Share by Company in 2022
Figure 28. Advanced Parenteral Drug Delivery Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Advanced Parenteral Drug Delivery Revenue Market Share by Company in 2022
Figure 30. Global Advanced Parenteral Drug Delivery Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Advanced Parenteral Drug Delivery Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Advanced Parenteral Drug Delivery Sales 2018-2023 (K Units)
Figure 33. Americas Advanced Parenteral Drug Delivery Revenue 2018-2023 ($ Millions)
Figure 34. APAC Advanced Parenteral Drug Delivery Sales 2018-2023 (K Units)
Figure 35. APAC Advanced Parenteral Drug Delivery Revenue 2018-2023 ($ Millions)
Figure 36. Europe Advanced Parenteral Drug Delivery Sales 2018-2023 (K Units)
Figure 37. Europe Advanced Parenteral Drug Delivery Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Advanced Parenteral Drug Delivery Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Advanced Parenteral Drug Delivery Revenue 2018-2023 ($ Millions)
Figure 40. Americas Advanced Parenteral Drug Delivery Sales Market Share by Country in 2022
Figure 41. Americas Advanced Parenteral Drug Delivery Revenue Market Share by Country in 2022
Figure 42. Americas Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Figure 43. Americas Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Figure 44. United States Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Advanced Parenteral Drug Delivery Sales Market Share by Region in 2022
Figure 49. APAC Advanced Parenteral Drug Delivery Revenue Market Share by Regions in 2022
Figure 50. APAC Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Figure 51. APAC Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Figure 52. China Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Advanced Parenteral Drug Delivery Sales Market Share by Country in 2022
Figure 60. Europe Advanced Parenteral Drug Delivery Revenue Market Share by Country in 2022
Figure 61. Europe Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Figure 62. Europe Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Figure 63. Germany Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Advanced Parenteral Drug Delivery Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Advanced Parenteral Drug Delivery Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Advanced Parenteral Drug Delivery Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Advanced Parenteral Drug Delivery Sales Market Share by Application (2018-2023)
Figure 72. Egypt Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Advanced Parenteral Drug Delivery Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Advanced Parenteral Drug Delivery in 2022
Figure 78. Manufacturing Process Analysis of Advanced Parenteral Drug Delivery
Figure 79. Industry Chain Structure of Advanced Parenteral Drug Delivery
Figure 80. Channels of Distribution
Figure 81. Global Advanced Parenteral Drug Delivery Sales Market Forecast by Region (2024-2029)
Figure 82. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Advanced Parenteral Drug Delivery Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Advanced Parenteral Drug Delivery Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Advanced Parenteral Drug Delivery Revenue Market Share Forecast by Application (2024-2029)

※参考情報

先進的非経口薬物送達は、薬物療法において、新たな技術や方法論を用いて、従来の経口投与以外の手段で薬物を体内に届けるための手段を指します。このような方法は、患者の治療効果を高めたり、副作用を最小限に抑えたりするために重要です。以下に、先進的非経口薬物送達の概念について詳しく述べます。

まず、非経口薬物送達の定義から始めます。非経口薬物送達とは、薬物を経口ではなく、静脈、筋肉、皮膚、または他の部位に直接投与する方法を指します。これには注射剤、インプラント剤、トランスデリバリーシステム（経皮吸収）、吸入治療などが含まれます。非経口薬物送達は、胃腸の影響を受けず、直接血液循環に入るため、薬物のバイオアベイラビリティ（生物学的利用率）が向上します。

次に、非経口薬物送達の特徴について考えます。まず、正確な投与量をコントロールしやすい点が挙げられます。特に、注射剤を使用する場合、医療従事者が直接コントロールできるため、効果的な薬物濃度を維持しやすくなります。また、経口薬物に比べて消化系への負担がなく、患者の体内に迅速に効果を発揮することができます。これは、急性の疼痛管理や、緊急医療において特に重要です。

非経口薬物送達の種類には、いくつかの方法があり、注射剤、経皮送達（トランスデリバリー）、吸入療法などがあります。注射剤はさらに、静脈注射、筋肉注射、皮下注射などに分類され、全身的または局所的効果を持つことができます。経皮送達は皮膚を通じて薬物を体内に取り込む方法であり、パッチ形式の製品が一般的です。この方法は、患者の服用に対する抵抗が少なく、連続的に薬物を投与する際に便利です。

用途について言及すると、非経口薬物送達は多くの治療に利用されています。例えば、糖尿病患者に対するインスリン注射、癌治療における化学療法薬の投与、疼痛管理のための麻薬の使用などが挙げられます。これらの治療法は、迅速な効果発現や効果の持続時間を考慮したものであり、時間を要する経口投与では得られない利点があります。

関連技術には、ナノテクノロジーやマイクロエレクトロニクス、バイオテクノロジーなどがあります。ナノテクノロジーを用いることで、薬物の粒子サイズを小さくして体内での吸収を促進したり、特定の細胞や組織にターゲットを絞って薬物を届けることが可能となります。また、マイクロエレクトロニクスの進歩により、自己投与できるデバイス（インプラントやポンプなど）が開発され、患者の負担を軽減しています。

安全性と有効性についても考慮する必要があります。非経口薬物送達は、多くの場合、直接的かつ迅速な効果を提供しますが、関連するリスクや副作用も伴います。特に注射部位の感染症やアレルギー反応には注意が必要です。これらを管理するため、医療従事者は患者に対する十分なケアと指導を行うことが求められます。

今後の展望としては、個別化医療の進展や、より効率的かつ安全な薬物送達システムの開発が期待されます。これにより、患者のニーズに応じた治療がより一層推進されるでしょう。また、新たな技術の導入により、より複雑な治療や薬物の送達が可能になることが予想されています。

つまり、先進的非経口薬物送達は、薬物の効果を最大化し、副作用を最小化するための重要な方法です。この分野は急速に進化しており、今後の医療の可能性を大きく広げる重要な鍵となるでしょう。患者にとっても、科学技術の進展による恩恵を受けることができる時代が到来しています。


★調査レポート[世界の先進的非経口薬物送達市場予測 2023年-2029年] (コード：LP23MY4002)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の先進的非経口薬物送達市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆